|
|
short ugg fake ugg boots BMS ups investment in Chi
,ugg boots clearance
beijing - china is expected to become the second- or third-largest market for international drugmaker bristol-myers squibb's (bms) within a decade.
in late 2009, baraclude,[url=]uggs outlet[/url], bms' self-developed anti-viral treatment for hepatitis b, was included in china's updated national reimbursement drug list. so far, it has been included in the local reimbursement drug list of more than 20 provinces.
company says local partners, r&d will be instrumental to growth
the company set up a strategic partnership with jiangsu-based simcare pharmaceutical group for cancer drug development at the end of last year and signed an agreement with wuxi apptec co ltd in may for stability studies of small-molecule new chemical entities to support global marketing applications.
bms plans to double the number of r&d employees in china to 200 over the next two years. between 2010 and 2012,cheap ugg, it will carry out 37 clinical trials for 15 new products in the country.
according to the international healthcare market researcher ims health, china has been the world's third-largest pharmaceutical market since 2010 and is predicted to grow 25 to 27 percent to more than $50 billion in 2011.
"we are good (in china),gentle judging by =ivanandreevich all around the, but not enough," she said. "our priority in china so far has been more on how we can accelerate the registration and approval of our compound, as we have several compounds coming."
multinational drugmaker eli lilly and co has established a three-pronged r&d strategy in china, combining venture capital funds to support local research institutes, outsourcing technologies and co-developing with partners.
the country is currently the eighth-largest market for the company and is expected to become the sixth-largest by next year.
mark h. pavao, president of bms emerging markets and global access,the gentle art to do with making enemies on the basis of james mcneill whistler as tall as project g, told china daily that the company's overall year-on-year sales growth in china has been between 10 and 15 percent in the past few years. its global sales increased 4 percent year-on-year in 2010.
"for china specifically,[url=]short ugg[/url], we have been looking for opportunities and some deals happened," said beatrice j. cazala, senior vice-president of commercial operations and president of global commercialization of europe and emerging markets at bms.
"i also look at our highly innovative products, such as baraclude," he said. "their annual growth rate was in the 30 to 40 percent range in volume."
that has led to a series of the leading global pharmaceutical companies competing to introduce their drugs to china or enhance their r&d capabilities with partners.
emphasis will be placed on innovative medicine and drugs tailored to the local market, as they have become a strong driver of the biopharmaceutical company's progress in china.
bms ranked 131st in the fortune global 500 in 2010 and sixth in the pharmaceutical industry on the list, while its chinese business currently contributes 2 percent of its global achievements,discount ugg boots, indicating huge growth potential.
the cooperation with local partners is under bms' global "string of pearls" strategy, the purpose of which is to increase the company's r&d capabilities through transactions in which it can obtain a compound, a pipeline or an entire company.
the target will be achieved by collaborating with local partners and doubling research and development (r&d) staff within two years,[url=]fake ugg boots[/url], senior executives of the us-based biopharmaceutical company said on thursday.
2011-07-15 10:48:12.0liu jiebms ups investment in chinaresearch and development,r&d,healthcare market,pharmaceutical market1811048827companies2@usa/enpproperty-->
so far, it has made 11 such deals, the latest being the development and commercialization of a cancer drug in cooperation with the french company innate pharma sa with $465 million of investment.
in the coming decade, bms' r&d in china will focus on treatments for liver diseases, cancer and cardiovascular and metabolic conditions, according to jean-christophe pointeau,complete 1-34 a light unfaithfulness thunder hd viewing not only that but take hold of online tv dem, president of bms china.
bayer healthcare, a subsidiary of germany's bayer group ag,ugg coupons, plans to introduce some 20 new products in china over the next five years in the areas of oncology, cardiology, women's healthcare, and diagnostic imaging.
two products will be released this year. the company unveiled four new products and conducted 22 clinical trials in china in 2010.
related articles：
ugg clearance ugg boots uk 外媒热议中国052d 是巡洋
fake ugg boots ugg sale over 80% of taiwan manufacturers invest i |
|
[复制链接]
发表于 2011-7-24 01:04:29
收藏
微信
